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Summary. The antiproliferative effects of bistramide A, a 
nitrogenous dilactam polyether from Lissocliizuiii bis- 
tratuiiz Sluiter (Urochordata), were studied at the level of 
the cell cycle in asynchronous cells of the NSCLCN6-Ll6 
line. Bistramide A has a dual mechanism that induces 
blockade in the G1 phase (compatible with differentiation 
properties reported elsewhere) and causes polyploidy that 
is suggestive of inaptitude for cytokinesis. These effects 
confirm the results of cytomorphology studies in electron 
microscopy. 
Introduction 
The prospective development of a new antitumor drug 
requires that its mechanism of action be understood early 
such that its utility can be assessed in comparison with that 
of substances in current clinical use. One simple means is 
to conduct flow cytometry studies of its effect on the cell 
cycle, a procedure used by us to determine the effect of 
bistramide A on a non-small-cell bronchial carcinoma line. 
Bistramide A (also known as bistratene, Fig. l), a dilac- 
tam polyether from the New Caledonian urochordate Lis- 
socliizitrn bistratum Sluiter [2, -51, is cytotoxic to normal 
and tumor cells and produces a rapid toxic effect on the 
central nervous system that can be attributed to inhibition 
of the Na+ channel both at rest and in the inactivated state 
[3, 61. The ia vivo activity ofthis substance against slowly 
developing tumors is currently being studied, particularly 
in a continuous human non-small-cell lung cancer cell line 
i(NSCLCNG-Ll6) [7, 91. The results of the in vitro studies 
described herein were obtained using this line. 
Ofii int  reqvests to: C. Roussakis 
Materials and methods 
Bistrainide A. Bistramide A (mol. wt., 701 kDa) \vas isolated from L 
bisfratztm collected at Ua island in New Caledonia as previously de- 
scribed [6]. The purity of the substance was determined by mass spec- 
trometry, infrared spectrometry, and HPLC cochromatography. 
Cell h i e  arid cell czrlticre. The cloned L16 line of NSCLC-N6 cells from 
a human non-small-cell bronchopulmonary carcinoma (moderately 
differentiated, rarely keratinizing; classified as TzNoMo) was used for all 
determinations. It was grafted into a nude mouse, then cultured in RPMI 
1640 medium (Intermed) with 5% fetal calf serum, to which 100 IU 
penicillinhl, 100 pg streptomycin/ml, and 2 mhi glutamine were added. 
Cells were cultured at 4 x IOs/ml at 37" C in an air-carbon dioxide (95 : 5,  
v/v) atmosphere. Under these in vitro conditions, the cell-doubling time 
was about 32 li, whereas it takes 24 days in vivo. 
Cyfoto.uicip detc2rn7ii7atior7. Experiments were performed in microplates 
(2.1 x 105 cells/ml). Bistramide A was tested at concentrations of 0.35, 
1.42, and 7.1 phi. Cell growth was estimated by a colorimetric assay 
based on conversion of tetrazolium dye (MTT) to a blue formazan 
product using live mitochondria [SI at 17, 25, 41, 49, and 67 h. Eight 
determinations were performed for each concentration. Control growth 
(without bistramide) was estimated from 16 determinations. The confi- 
dence intervals in Fig. 2 represent the standard deviations calculated for 
each of the points. 
Flaw cytonzety assay. For DNA staining, 2.1 x lo* cells were cultured in 
25-ml flasks in the absence as well as the presence of 0.35, 0.71, a id  
1.42 pf bistramide A. Determinations were performed at 24,45,71, and 
94 h. As the NSCLCN6-LI6 line shows a very strong capacity for 
adherence, DNA staining was carried out using the technique of Vin- 
delov [ I l ] .  The cells were directly treated in the flask with the staining 
solution, which destroys the cytoplasm before staining. After the remov- 
al of culture medium, 1 ml Vinddov's solution [0.01 M glycineMaOH; 
9 . 6 ~  1 0 - S ~  propidium iodide (Sigma P 5264); 0.1 M Nonidet P-40 
(Sigma N 6507); 700 Tu ribonuclease AA (Sigma R 5250); 0.3 h.~ NaCI; 
pH 101 diluted i : 2 (v/v) in phosphate-buffered saline was dropped into 
the flasks, which were then shaken and left in a dark environment at 4" C 
for 15 min. The cell suspension thus obtained was filtered on nylon mesh 
(50 pm) and analyzed. 
All flow cytometry experiments were performed independently eight 
times. The DNA content of 25,000 naked nuclei was measured by an 
ATC 3000 flow cytometer (Bruker, Wissembourg, France) connected to 
an MCA 3000 multichannel analyzer (Bruker). Propidium iodide was 
excited (488 nm) using an argon laser (Innova 90.5 UV, Coherent L a e r  
Products Division, Palo Alto, Calif.) at 400 mW. Fluorescence was mea- 
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Fig. 4 a, b. DNA histogram of NSCLCN6-L16 cells cul- 
tured in the presence of different concentrations of bis- 
tramide (0.035,0.71, and 1.42 p i )  for 74 h. a After 74 h 
culture in the presence of bistramide, “damaged” cells are 
increased and produce considerable debris at 0.7 1 p~. The 
effect at 45 h i s  intensified “8C” cells are apparent in large 
number at 0.35 p~ bktramide, are nonexistent at 1.42 p, 
and occur infrequently at 0.7 1 ~ L M .  b By means of an addi- 
tional gate on the DNA vs FALS cytogram, the most 
fluorescent cells corresponding to the “4C” and ‘“2’’ chro- 
mosome peaks me selected to enhance visualization of the 
“8C” peak as a function of the bistrainide concentration 
used 
Fig. 5. Effect of 1.42 phi bistramide as a function of culture 
time (2445, or 74 h). 0, Bistramide; D, control. 
Beginning at 34 h, an increase can be noted in the “2C” and 
“4C” peaks to the detriment of the S phase as compared 
with the control. With the passage of time, the peak “2C” 
cells increase, a stable residual S phase subsists, and the per- 
centage of peak “4C” cells decrease. The amount of debris 
is increased at 74 h, indicating cell mortality 
Fig. 6. Effect of 0.35 p f  bishamide as a function of culture 
time (45,74, or 94 h). O, Bistramide; D, control. At 
45 h, 0.35 phi bistramide causes a significant decrease in 
the number of S-phase cells, the appearance of an “8C” 
peak, and the persistence of the “4C” peak. At 72 h, an in- 
tensification of the phenomenon is visualized, particularly 
an increase in the “8C“ and “4C” peaks. At 94 li, the pres- 
ence of debris related to high cell moitality partially masks 
the three peaks (“2C”, “4C”. and ‘“3. The increased CV 
of the corresponding control “2C” peak is due to a decrease 
in growth factors in the cell-culture medium 
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ter) and displayed a reduced size (0.5- 1 pm) in nearly all 
tumor cells (Fig. 11). Some cells also contained very clear 
vacuoles (never more than 3-4 pm in diameter) lined with 
microfilaments. 
Cultivation of tumor cells in the presence of high drug 
concentrations (1.4 p ~ )  led to cell death and. hence, to the 
absolute impossibility of analyzing cells ultrastructurally. 
When concentrations of O. 175-0.35 p~ were used, inipor- 
tant changes took place in the behavior of the cell culture. 
Cell degeneration and necrosis occurred more frequently, 
and the heterogeneity of the features observed in living 
cells was remarkable. There were many isolated cells in 
which elements undergoing mitosis were frequently seen. 
Cell groups were also observed, with the digitations being 
essentially responsible for the adhesion process. However, 
in the presence of bistramide, there was differentiation of 
specialized junctions such as desmosomes (Figs. 12, 13). 
When these ultrastructures were present, the plasma mem- 
branes of two adjacent cells put vast areas of parallel linear 
membrane into common use by providing a narrow inter- 
cellular space. Specific receptor-exchange phenomena 
probably occurred between adjacent cells under these con- 
ditions, since clathrine-coated cytosis vesicles could be 
found (Fig. 13). 
The lipid droplets and clear vacuoles scattered through 
the hyaloplasm did not disappear but were less frequently 
observed. The chondriome of many cells was found 
against the nuclear membrane around the nucleus. Every- 
thing in this respect occurred as if the available energy 
were focused on the nuclear material, presumably in prep- 
aration for cell division (Fig. 15). Other cells contained 
mitochondria showing unusual features of size (7-8 pm 
and sometimes larger) and shape and an anarchic arrange- 
ment of the crests (Fig. 14). Internal cavities also appeared 
in treated tumor cells. These cavities were very large 
(sometimes >15 pm) and were lined with microvilli. How- 
ever, the slightly opaque content of the electrons was 
different from than that observed in intercellular spaces. 
Close study of these internal cavities would probably be of 
considerable interest but did not lie within the scope of the 
present work. Nonetheless, it may at least be deduced from 
our observations that the cavities correspond to a particular 
production of bistramide-treated tumor cells. Cavities 
delimited by two or three cells grouped in pseudoglandular 
formation were also noted (Fig. 12). 
At a bistramide concentration of 0.35 p ~ ,  cell sections 
exhibiting two nuclei separated by a hyaloplasinic layer of 
variable thickness (sometimes very thin) were quite 
frequently seen (Fig. 12). These were not different sections 
of the same notched nucleus, since such sections would 
have had very regular and roughly rounded contours. It is 
true that nuclei with a very irregular and notched contour 
could also be observed, but they composed only a minority 
of the nuclear population. Cell sections with three and even 
four nuclear sections were assiduously sought and found 
Fig. 17). Given the scale at which our observations were 
carried out, it is true that nuclei were not always included 
in a section and that the presence of three nuclear sections 
in the same cell most often implied the presence of at least 
four nuclei. However, the possibility that the cells had an 
uneven number of nuclei (e.g., three) cannot be excluded. 
Results 
Cytotoxicity 
Figure 2 shows the growth of NSCLCN6-L16 cells in the 
absence as well as in the presence of 0.35, 1.42, and 7.1 p~ 
bistramide A as determined at different time points. The 
concentration of drug required to inhibit cell growth by 
50% (Ic50) was 0.49 at 67 h. 
Efsects ori the cell cycle 
Figures 3 and 4 show the effects of bistramide A on the cell 
cycle according to concentration. A blockade of cells in the 
G 1 phase was demonstrated by a dose-dependent decrease 
in S-phase cells. However, the persistence of a “4C” peak 
was simultaneously noted G 1-phase cells, even following 
treatment with 1.42 p~ bistramide, at 45 (Fig. 3) and 74 h 
(Fig. 4 4 .  At lower concentrations (0.35 and 0.71 p~), par- 
tial blockade occurred in the G1 phase along with the 
appearance of polyploidy. 
Figures 5 and 6 illustrate the time-dependent effects of 
bistranlide A on the cell cycle. A blockade of GI-phase 
cells was noted at 24 h following treatment with 1.42 pM 
drug (Fig. 5). At between 4 and 24 h, the percentage of 
S-phase cells decreased in a time-dependent manner (data 
not shown). At the time at which bistramide was added, 
S-phase cells of the asynchronous culture continued their 
progression in the cell cycle, and a nearly stable state was 
maintained from 24 h on at a drug concentration of 
1.42 p1.  The appearance of debris and the increased 
coefficient of variation (CV) of the “2C” peak at 74 h could 
be considered to be indices of cell mortality. However, in 
the presence of 0.35 p~ bistrainide A (Fig. 6), partial G1- 
phase blockade and the appearance of polyploidy were 
significant from 45 h onward. These two effects were even 
more marked at 72 h, whereas extremely high cell mortal- 
ity was observed at 94 h. 
Ultl-nstnrctiir-al nnnlysis 
The series of ultrastructural images showed that in the 
absence of bistramide treatment tumor cells form interde- 
pendent groups (Fig. 7) and that isolated cells occur in- 
frequently. The phenomena of intracellular recognition are 
such that the cells produce peripheral digitations that mesh 
with those of adjacent cells (Fig. 8). The cells are thus 
squeezed against each other, becoming deformed by their 
mutual pressure. Images indicating lysis or cell degenera- 
tion were extremely rare. Signs of mitosis could be ob- 
served, albeit infrequently, and attested essentially to the 
asynchronism of the culture, which was conoborated by 
the variable features of elements in cells that were in an 
interphasic state (Fig. 9). In fact, most of the cells dis- 
played a dark. reduced cytoplasm, with only a few showing 
a larger, clear cytoplasm that was richer in differentiated 
cell constituents. The most remarkable of these constitu- 
ents involved the mitochondria (Fig. lo), which were often 
seen in association with lipid droplets (1 -2 pm in diame- 

289 
Fig. 12. General view of a tumor-cell culture treated with bistramide 
(0.35 pi medium). Two binuclear cells (.Y) and two cells in pseudoglan- 
dular formation surround a central cavity (CC). Three desmosomes 
(circle) can be seen in this group of four very interdependent cells. 
x 4,200 
Fig. 13. Detail of the intercellular junctions, showing two characteristic 
desmosomes (arrows). go, Golgi complex. h e r :  Detail of a coated 
vesicle (urrow) and another desmosome. x 12,000 
Fig. 14. Portion of a tumor cell treated with 0.35 pi bistramide. Two 
giant mitochondria ( m g )  are visible next to mitochondria of normal size 
(in).  x 7,000 
16 
29 1 
cal modifications assimilable to cell maturation in the 
NSCLCN6-L16 line after treatment with 0.35 pht bis- 
tramide for 45 h: the appearance of junction systems such 
as desmosomes after the plasma membranes of adjacent 
cells have been brought closer together is highly sugges- 
tive of cell maturation. Likewise, the presence of coated 
vesicles attests to a process of differentiation as well as to 
intercellular communication. However, the general phe- 
nomena described herein are not definitive markers of 
differentiation. This potential property of NSCLC requires 
more thorough investigation. Furthermore, we also consid- 
ered in detail the potential differentiating properties of this 
substance on NSCLC. 
The induction of polyploidy by bistramide, which 
seems to be inversely proportional to the concentration 
used, is in fact simply the result of dose-dependent 
blockade of G1-phase cells and of the incapacity of cells to 
achieve cytodieresis. At low concentrations, cells that are 
not blocked in the G1 phase (“2C”) attain the G2M phase. 
Their incapacity to divide leads to the entry of binuclear 
cells (“4,”) into the cell cycle, some of which are partially 
blocked in the G1 phase, with a resulting increase in the 
intensity of the “4C” peak. This process also occurs in 
nonblocked cells, resulting in the appearance of a quad- 
rinuclear cell peak (“8C”). This polyploidy was confirmed 
by electron microscopy studies. 
The study of the cell cycle as a function of bistrainide 
concentration and contact time thus shows that inhibition 
of cytodieresis occurs at doses lower than those inducing 
maximal blockade of GI-phase cells by aputative differen- 
tiation process. 
Ackrzait~led~enzeiits. The authors thank Mr. J. Le Boterff, Mrs. J. Valton, 
Miss C. Boré and Mrs. M. Berreur for their technical collaboration and 
the Association de Recherche en Cancérologie (ARC) for material assis- 
tance. 
If the karyokinetic stages occurring after the first one are 
asynchronous, the cell involved must necessarily contain 
an uneven number of nuclei at a given moment. In fact, we 
observed a cell containing two nuclei that were at veiy 
different stages of maturation (Fig. 16). In general, it may 
be that nuclear but not cellular divisions are possible in a 
tumor-cell culture in the presence of low concentrations of 
bistramide: karyokinesis is apparently not followed by cy- 
tokinesis. 
Discussion 
As previously demonstrated [3,6], bistramide A has dose- 
dependent cytotoxic properties, particularly for the 
NSCLC line. The content of DNA in flow cytoinetry stud- 
ies was proportional to the intensity of cell fluorescence 
and, thus, to the quantity of intercalary fluorochrome fixed 
by the double strands of DNA. Consequently, GO- and 
GI  -phase cells were indistinguishable from each other, as 
were G2/M-phase cells from “2C” doublets or binuclear 
cells. In fact, nuclear staining using the technique of Vin- 
delov [ I l ]  does not lead to total destruction of the cyto- 
plasm, the result being that the nuclei of binuclear or poly- 
ploid cells are not dissociated. This was confirmed by 
fluorescence microscopic observation of the suspension 
analyzed in flow cytometry. 
Despite the gate provided on the cytogram “DNA area 
vs DNA peak”, doublets and triplets were analyzed as if 
they were single cells with “4C” or “6C” chromosomes. 
The presence of residual triplets on the treated cells and the 
control histogram was easily detectable and enabled the 
overestimated number of “4C” or “8C” cells to be cor- 
rected. In the interpretation of the results, this factor of 
error was taken into account. However, it may have only 
reflected mitotic asynchronism subsequent to the first divi- 
sion of treated cells. The ultrastructural data are entirely 
compatible with this interpretation. 
During study of the mode of action of a drug, when 
culture times are long, cell mortality is normal and debiis 
appears. If the debris were eliminated by a gate on the 
FALS vs DNA peak or the FALS vs WALS cytograms, 
S-phase overestimation would be possible. Therefore, it 
seemed preferable to let the debris appear, to the detriment 
of the appearance of the DNA histogram. Elimination of 
this debris would have been possible by mathematical 
treatment of the histograms, but too many data would have 
been removed logarithmically and the resulting histogram 
would not have been reliable. 
The results of this study clearly show the antiprolifera- 
tive effect of bistrainide on asynchronous cultures of the 
cloned line (NSCLCN6-LI 6) through its action on the cell 
cycle. Bistramide acts by a dual mechanism involving the 
blockade of GI-phase cells and the appearance of poly- 
ploidy that is suggestive of inaptitude for cytodieresis. 
The blockade of G 1-phase cells is in agreement with the 
results of previous studies in which this molecule was 
presented as an agent of cell differentiation with respect to 
non-small-cell bronchial carcinomas [ 1 O] and, in certain 
aspects, to the HL 60 monocytic line of leukemic origin 
[ 121. This hypothesis is also supported by the morphologi- 
References 
1. Barlogie B. Drewiilko B, Johnston DA, Buchner T, Haus  JW, 
Freireich EJ ( 1976) Pulse cytophotometric analysis of synchronised 
cells in vitro. Cancer Res 36: 1 176- 1 18 1 
2. Degan BM, Hawkins CH, Lavin MF (1989) Novel cytotoxic com- 
pounds from the ascidian Lissocliiziirii bistrcifirrn. J Med Chem 32: 
3. Ecault E, Gouiffes-Barbin D, Sauviat MP, Verbist JF (1991) 
Blockade of sodium channels by bistramide A in voltage-clamped 
frog skeletal muscle fibres. Biochem Biophys Acta (in press) 
4. Fried J, Mandel M (1979) Multi-user system for analysis of data 
from flow cytometry. Comput Programs Biomed 10: 218-230 
5. Gouiffes D, Moreau S, Helbecque N, Bernier JL, Henichxt JP, 
Barbin Y, Laurent D, Verbist JF (1988) Proton nuclear magnetic 
study of bistramide A, a new cytotoxic drug isolated from Lissa- 
cliriiiiiz bistiafim Sluiter. Tetrahedron 44: 45 1 -459 
6. Gouiffes D, Jugé M, Grimaud N, Wellin L, Gauviat MP, Barbin V, 
Laurent D, Roussahis C, Henichart JP, Verbist JF (1988) Bistramide 
A, a new toxin from the Urochordata Lissoclirzirrii histmtirni Sluiter: 
isolation and preliminary characterization. Toxicon 26: 1129- 1136 
7. Gratas C, Robillard N, Roussakis C, Audouin AF, Verbist JF (1990) 
Study of the heterogeneity of a human non-small-cell bronchopul- 
monary epidermoid primary carcinoma: determination of the DNA 
content of NSCLCN6L2 cells and of cloned sub-populations. Bio1 
Cell 68: 133- 138 
1354- 1359 

